Dr. Nellwyn Hagan is a principal scientist and project leader at Sanofi with a strong background in preclinical research and drug discovery for neurological diseases. Ongoing work in the Precision Neurology Group focuses on understanding neuroglial interactions in neurodegeneration and harnessing this knowledge to develop therapeutic interventions that will reduce neuroinflammation and provide neuroprotection.